InvestorsHub Logo
Followers 971
Posts 382998
Boards Moderated 11
Alias Born 06/24/2011

Re: None

Wednesday, 09/20/2017 1:08:50 PM

Wednesday, September 20, 2017 1:08:50 PM

Post# of 197513
$PSID hearing government contracts coming! Panel participants shared several insights on recent advancements in the pathogen detection field that had recently come to market or were on the near horizon. Case in point, Probst pointed to ExcitePCR’s FireflyDX technology platform, which utilizes a patented microfluidic-based cartridge that incorporates on-board sample preparation as part of ExcitePCR’s polymerase chain reaction-based pathogen detection systems. Internal Sample Preparation, Small Size and Rapid Results Differentiate the FireflyDX Systems, says Lyle Probst During BioWatch Panel
https://finance.yahoo.com/news/internal-sample-preparation-small-size-120000072.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.